A serious medical problem that oncologists face is multi-drug resistant cancers. In order to address this issue, Guillermo Aquino-Jarquín from the Children's Hospital Federico Gómez of Mexico, seeks expression profiles ...
May 29, 2015
0
7
Loss of TLK1 and TLK2 results in extensive DNA damage during DNA replication and in cancer cell death. Depletion of TLK1/2 enhances the effectiveness of some chemotherapeutic agents currently being tested in clinical trials
Aug 9, 2018
0
0
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential ...
Dec 4, 2012
0
0
A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. Based on these promising results ...
Jun 10, 2019
0
1
A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget.
Mar 25, 2024
0
0
